FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2323293892> ?p ?o ?g. }

• W2323293892 endingPage "711" @default.
• W2323293892 startingPage "685" @default.
• W2323293892 abstract "Until recently, vitamin K antagonists (VKAs) were the only available oral anticoagulants evaluated for long-term treatment of patients with coronary heart disease (CHD), particularly after an acute coronary syndrome (ACS). Despite efficacy in this setting, VKAs are rarely used because they are cumbersome to administer. Instead, the more readily manageable antiplatelet agents are the mainstay of prevention in ACS patients. This situation has the potential to change with the introduction of non-VKA oral anticoagulants (NOACs), which are easier to administer than VKAs because they can be given in fixed doses without routine coagulation monitoring. The NOACs include dabigatran, which inhibits thrombin, and apixaban, rivaroxaban and edoxaban, which inhibit factor Xa. Apixaban and rivaroxaban were evaluated in phase III trials for prevention of recurrent ischaemia in ACS patients, most of whom were also receiving dual antiplatelet therapy with aspirin and clopidogrel. Although at the doses tested rivaroxaban was effective and apixaban was not, both agents increased major bleeding. The role for the NOACs in ACS management, although promising, is therefore complicated, because it is uncertain how they compare with newer antiplatelet agents, such as prasugrel, ticagrelor or vorapaxar, and because their safety in combination with these other drugs is unknown. Ongoing studies are also now evaluating the use of NOACs in non-valvular atrial fibrillation patients, where their role is established, with coexistent ACS or coronary stenting. Focusing on CHD, we review the results of clinical trials with the NOACs and provide a perspective on their future incorporation into clinical practice." @default.
• W2323293892 created "2016-06-24" @default.
• W2323293892 creator A5000194670 @default.
• W2323293892 creator A5007123733 @default.
• W2323293892 creator A5016304798 @default.
• W2323293892 creator A5021188751 @default.
• W2323293892 creator A5030243760 @default.
• W2323293892 creator A5033437254 @default.
• W2323293892 creator A5033831989 @default.
• W2323293892 creator A5038405190 @default.
• W2323293892 creator A5039450208 @default.
• W2323293892 creator A5041318172 @default.
• W2323293892 creator A5044800174 @default.
• W2323293892 creator A5057062433 @default.
• W2323293892 creator A5058415494 @default.
• W2323293892 creator A5061992582 @default.
• W2323293892 creator A5063591215 @default.
• W2323293892 creator A5065978967 @default.
• W2323293892 creator A5067302152 @default.
• W2323293892 creator A5077862111 @default.
• W2323293892 creator A5078073832 @default.
• W2323293892 creator A5082464840 @default.
• W2323293892 creator A5084461040 @default.
• W2323293892 creator A5091851552 @default.
• W2323293892 date "2016-01-01" @default.
• W2323293892 modified "2023-10-02" @default.
• W2323293892 title "Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease" @default.
• W2323293892 cites W1532321223 @default.
• W2323293892 cites W1564690174 @default.
• W2323293892 cites W158289124 @default.
• W2323293892 cites W1705023383 @default.
• W2323293892 cites W1741176642 @default.
• W2323293892 cites W1886686547 @default.
• W2323293892 cites W1914259002 @default.
• W2323293892 cites W1932040470 @default.
• W2323293892 cites W1959701674 @default.
• W2323293892 cites W1970914415 @default.
• W2323293892 cites W1973598956 @default.
• W2323293892 cites W1978995142 @default.
• W2323293892 cites W1979363567 @default.
• W2323293892 cites W1985397601 @default.
• W2323293892 cites W1990030978 @default.
• W2323293892 cites W1991549653 @default.
• W2323293892 cites W1996056369 @default.
• W2323293892 cites W2005936100 @default.
• W2323293892 cites W2006346111 @default.
• W2323293892 cites W2010152642 @default.
• W2323293892 cites W2011568736 @default.
• W2323293892 cites W2020759112 @default.
• W2323293892 cites W2022506351 @default.
• W2323293892 cites W2024352468 @default.
• W2323293892 cites W2028582098 @default.
• W2323293892 cites W2032105970 @default.
• W2323293892 cites W2043964965 @default.
• W2323293892 cites W2046051565 @default.
• W2323293892 cites W2046367794 @default.
• W2323293892 cites W2047740656 @default.
• W2323293892 cites W2061468970 @default.
• W2323293892 cites W2074585167 @default.
• W2323293892 cites W2076472818 @default.
• W2323293892 cites W2077715397 @default.
• W2323293892 cites W2083173946 @default.
• W2323293892 cites W2084124265 @default.
• W2323293892 cites W2085495583 @default.
• W2323293892 cites W2090120321 @default.
• W2323293892 cites W2094875652 @default.
• W2323293892 cites W2095524309 @default.
• W2323293892 cites W2096246254 @default.
• W2323293892 cites W2097854437 @default.
• W2323293892 cites W2098837786 @default.
• W2323293892 cites W2099069840 @default.
• W2323293892 cites W2100089051 @default.
• W2323293892 cites W2100209149 @default.
• W2323293892 cites W2105210342 @default.
• W2323293892 cites W2105397247 @default.
• W2323293892 cites W2107371049 @default.
• W2323293892 cites W2108064339 @default.
• W2323293892 cites W2108570679 @default.
• W2323293892 cites W2108659563 @default.
• W2323293892 cites W2109577952 @default.
• W2323293892 cites W2113659056 @default.
• W2323293892 cites W2114995492 @default.
• W2323293892 cites W2115371613 @default.
• W2323293892 cites W2117677020 @default.
• W2323293892 cites W2121136766 @default.
• W2323293892 cites W2121366426 @default.
• W2323293892 cites W2122594641 @default.
• W2323293892 cites W2123262447 @default.
• W2323293892 cites W2125043491 @default.
• W2323293892 cites W2125336138 @default.
• W2323293892 cites W2126417439 @default.
• W2323293892 cites W2127090290 @default.
• W2323293892 cites W2130928146 @default.
• W2323293892 cites W2131110587 @default.
• W2323293892 cites W2136520492 @default.
• W2323293892 cites W2140501627 @default.
• W2323293892 cites W2141358924 @default.
• W2323293892 cites W2141610267 @default.

• next